Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 17/20 | 0.59 |
| ▸ | CCR4 | P51679 | 2/20 | 0.59 |
| ▸ | CNR2 | P34972 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5576569 | 1.00 | CCR5 (0.59) | CCR5CCR4CNR2 | |
| SCHEMBL5575998 | 0.89 | CCR5 (0.74) | CCR5CCR4 | |
| SCHEMBL5575994 | 0.89 | CCR5 (0.74) | CCR5CCR4 | |
| SCHEMBL4597391 | 0.86 | CCR5 (0.59) | CCR5CCR4 | |
| SCHEMBL4597397 | 0.86 | CCR5 (0.59) | CCR5CCR4 | |
| SCHEMBL4597757 | 0.85 | CCR5 (0.80) | CCR5CCR4 | |
| SCHEMBL5576651 | 0.85 | CCR5 (0.80) | CCR5CCR4 | |
| SCHEMBL4597753 | 0.85 | CCR5 (0.80) | CCR5CCR4 | |
| SCHEMBL5576657 | 0.85 | CCR5 (0.80) | CCR5CCR4 | |
| SCHEMBL5576676 | 0.80 | CCR5 (0.62) | CCR5CCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070066624-A1 | Chemokine receptor binding compounds | ANORMED, INC. (CA) | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066624-A1 | Chemokine receptor binding compounds | CCR5, CCR4, CCR1 | CCR5 1/4885CCR4 2/4885CNR2 191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.